Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT
NCT ID: NCT01907750
Last Updated: 2016-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
180 participants
INTERVENTIONAL
2009-01-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EBD RCT Trial in Living Donor Liver Transplantation
NCT04622540
Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups
NCT06767553
Stented Biliary Anastomosis in Living Donor Liver Transplantation
NCT03636321
Study to Establish Whether the Use of T-Tube in Bile Duct Anastomosis in Liver Transplantation Decreases Morbidity
NCT01546064
Intraductal Transanastomotic Stent in Duct-to-duct Biliary Reconstruction in Liver Transplantation
NCT04804215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A 4F or 5F biliary catheter (Marquat Genie biomedical, france) is used in all cases.
the study is to compare the effectiveness and safety of 2 different placement techniques:
1. the usual trans-anastomotic position (the tube is placed across the anastomosis line with the tip inside the intrahepatic biliary branches) through an opening in the wall of the recipient's common bile duct
2. a transcystic non-anastomotic position (the tube is placed through the cystic duct opening into the distal common bile duct not passing through anastomosis)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transanastomotic tube
use of transanastomotic tube.
biliary drainage tube
Transcystic tube
use of transcystic tube to drain bile duct
biliary drainage tube
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biliary drainage tube
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* single bile duct in the graft
Exclusion Criteria
2 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Mohammad Ahmad Sultan
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmad M Sultan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Gastro-enterology surgical center, Mansoura University
Mohammed Abdul-Wahab, MD, PhD
Role: STUDY_CHAIR
Gastro-enterolgy surgical center, Mansoura University
Tarek Salah, MD, PhD
Role: STUDY_DIRECTOR
Gastro-enterolgy surgical center, Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gastro-enterolgy surgical center, Mansoura University
Al Mansurah, Al-Dakahleia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Biliary_TCvsTA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.